Skip to main content

Day: September 5, 2025

Extraordinary General Meeting 5 September 2025 – Nykredit Realkredit A/S

To Nasdaq Copenhagen 5 September 2025 Nykredit Realkredit A/S – Extraordinary General Meeting 5 September 2025 At Nykredit Realkredit’s Extraordinary General Meeting held on Friday 5 September 2025, the shareholders:Approved the Board of Directors’ proposal for a revised Remuneration Policy.Copenhagen, 5 September 2025 Nykredit Realkredit A/SBoard of Directors ContactQuestions may be addressed to Press Relations, tel +45 31 21 06 39.AttachmentDecisions of extraordinary general meeting – Nykredit Realkredit AS – 05092025

Continue reading

American National Announces Full Redemption of Outstanding Depositary Shares Representing Interests in its 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B and Intent to Voluntarily Delist and Deregister

HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) — American National Group Inc. (the “Company”) (NYSE: ANG PRB) today announced that the Company will redeem (the “Redemption”) all the 12,000 outstanding shares of its 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B (the “Series B Preferred Stock”) and the corresponding 12,000,000 depositary shares, each representing a 1/1,000th interest in one share of Series B Preferred Stock (the “Depositary Shares”), on October 6, 2025 (the “Redemption Date”). The Depositary Shares will be redeemed for a redemption price equal to $25.00 per Depositary Share (equivalent to $25,000 per share of Series B Preferred Stock) plus an amount equal to any declared but unpaid dividends and the portion of the quarterly dividend attributable to 1/1,000th of a share of Series B Preferred Stock to...

Continue reading

Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics will present at the H.C. Wainwright 27th Annual Global Investment Conference being held from September 8-10, 2025 in New York, NY.  In addition to the presentation, management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website.  A video webcast of the presentation will be accessible for viewing on-demand beginning on Friday, September 5, 2025, at 7:00 AM ET for...

Continue reading

Spar Nord Bank A/S – Extraordinary General Meeting

Company announcement no. 27 At Spar Nord Bank A/S’s Extraordinary General Meeting held on Friday 5 September 2025, the shareholders:Approved the Board of Directors’ proposal for a revised Remuneration Policy. The Remuneration Policy had been updated following Nykredit’s acquisition of Spar Nord Bank A/S. Approved the amendment of the Company’s Articles of Association. A resolution was passed to amend the Company’s Articles of Association in accordance with the proposal set out in the Notice of 14 August 2025.Spar Nord Bank A/S Board of DirectorsAttachmentNo. 27 – Extraordinary GM – UK

Continue reading

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1×1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025. Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference Date: Thursday, September 11, 2025Location: New York, NY1×1 meetings only About Biodesix Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease....

Continue reading

Sono Group N.V. Announces Nasdaq Uplisting Approval and New Ticker Symbol “SSM”

Strategic move enhances liquidity, expands investor reach, and reinforces Sono’s position in the global solar technology market Munich, Sept. 05, 2025 (GLOBE NEWSWIRE) — The solar technology company Sono Group N.V. (NASDAQ: SSM) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH, hereafter referred to as “SonoSolar” or “Subsidiary”) today announced that it has received approval to uplist its ordinary shares from the OTCQB Venture Market to the Nasdaq Capital Market. The Company’s shares are expected to commence trading on Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “SSM” today Friday, September 5, 2025. The uplisting to Nasdaq represents a significant milestone in Sono’s growth trajectory, underscoring its strengthened financial position by converting its debt to preferred equity,...

Continue reading

3 Lucky Players Share $180,000 in the9bit’s August Fiesta Finale

the9bit Celebrates Global Launch and Nears 2 Million Users in Under Two MonthsSingapore, Sept. 05, 2025 (GLOBE NEWSWIRE) — the9bit, an innovative gaming platform backed by The9 Limited (NASDAQ: NCTY), has concluded its $1 Million August Fiesta campaign, awarding $180,000 in the grand finale airdrop to 3 winners. Running throughout August 2025, the event marked the platform’s global launch and celebrated its rapid growth, distributing $1 million in total prizes across three phases to reward active gamers and creators.The campaign was designed to transform everyday gaming habits into rewarding opportunities. Phase 1 (August 1–15) distributed $100,000, Phase 2 (August 16–20) delivered $400,000, and the final Phase 3 (August 24–31) closed the event with $600,000. The finale featured a raffle system where winners were randomly selected...

Continue reading

Extraordinary General Meeting 5 September 2025 – Nykredit Bank A/S

To Nasdaq Copenhagen 5 September 2025 Nykredit Bank A/S – Extraordinary General Meeting 5 September 2025 At Nykredit Bank’s Extraordinary General Meeting held on Friday 5 September 2025, the shareholders:Approved the Board of Directors’ proposal for a revised Remuneration Policy.Copenhagen, 5 September 2025 Nykredit Bank A/SBoard of Directors ContactQuestions may be addressed to Press Relations, tel +45 31 21 06 39.AttachmentDecisions of extraordinary general meeting – Nykredit Bank AS – 05092025

Continue reading

PONY AI Inc. and Mowasalat Deploy Robotaxi on Public Roads in Doha, Qatar

DOHA, Qatar, Sept. 05, 2025 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced a partnership with Mowasalat (“Karwa”), Qatar’s largest transportation service provider, together deploying autonomous vehicles on the country’s roads. This collaboration represents another significant step in Pony.ai’s vision of “autonomous mobility everywhere” and further expands its presence in the Middle East, now covering Dubai, Qatar, and other key markets. Under this partnership, Pony.ai’s Robotaxis have recently begun testing on public roads in Doha, the capital of Qatar. This initial phase, conducted with safety operators onboard, marks an important milestone in localizing autonomous driving technology for Qatar’s unique...

Continue reading

Bankruptcy proceedings initiated for AB Šatrija

On 4 September 2025, the Šiauliai Regional Court ruled to initiate bankruptcy proceedings for AB Šatrija, a sewing services company owned by the Utenos Trikotažas Group. The ruling may be appealed within 7 days of delivery. Once it becomes final, AB Šatrija will acquire the status of a bankrupt legal entity. Insolvency administrator Juozas Valaitis has been appointed (Insolvency Administrators List No. N-FA0207, address: Jonavos g. 16A, Kaunas, tel. +370 37 308945, email: biuras@adminbiuras.lt). Until the ruling enters into force, the company’s fixed assets, real estate, and property rights classified as current assets remain under seizure. This part of the ruling on asset seizure is enforceable immediately. This process will have no impact on the operations of Utenos Trikotažas or the implementation of its restructuring plan. The activities...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.